Tory 90 Tablet(Etoricoxib 90)30’s

Buy Tory 90 Tablet (Etoricoxib 90) 30’s Online Now in Nairobi, Kenya – Effective Pain Relief for Rheumatoid Arthritis

Tory 90 Tablet (Etoricoxib 90) 30’s is a specialized Non-Steroidal Anti-Inflammatory Drug (NSAID) formulated to deliver targeted relief for patients with rheumatoid arthritis. Designed to reduce pain, inflammation, and fever, this tablet harnesses the power of Etoricoxib to selectively inhibit cyclooxygenase-2 (COX-2)—the enzyme primarily responsible for generating prostanoid mediators of pain and inflammation. Its precision in action not only provides effective symptom relief but also minimizes gastrointestinal (GI) toxicity, a common concern with conventional NSAIDs.

Product Overview and Key Features

Tory 90 Tablet (Etoricoxib 90) 30’s is particularly crafted for individuals suffering from rheumatoid arthritis. Its formulation focuses on delivering a 90 mg dose of Etoricoxib per tablet, ensuring that the medication is potent enough to manage inflammation and pain associated with this chronic condition. This product is available in a pack of 30 tablets, making it an ideal choice for daily management and consistent treatment.

Why Choose Tory 90 Tablet (Etoricoxib 90) 30’s?

• Targeted Rheumatoid Arthritis Relief: Formulated specifically at a 90 mg dosage, this tablet offers optimal pain reduction and inflammation control for rheumatoid arthritis.significantly reduces the risk of GI complications compared to non-selective NSAIDs.
• Enhanced Safety Profile: By selectively inhibiting COX-2, Tory 90 Tablet 
• Convenient Dosing: With a once-daily regimen, it fits seamlessly into your daily routine, ensuring ease of use and better treatment adherence.
• Rapid Action: Designed to deliver fast relief, it enables patients to resume daily activities with minimal interruption.
• Quality Assured: Manufactured under stringent quality control measures, ensuring both safety and efficacy for long-term management of rheumatoid arthritis.

Indications and Dosage Guidelines

Tory 90 Tablet (Etoricoxib 90) 30’s is specifically indicated for the relief of pain and inflammation in patients with rheumatoid arthritis. For effective management of rheumatoid arthritis, the recommended dosage is one 90 mg tablet taken once daily. This formulation is not intended for other conditions such as osteoarthritis, dysmenorrhoea, or acute gout, which require different dosing regimens.

It is crucial to adhere strictly to your healthcare provider’s instructions regarding dosage. The precise 90 mg formulation is designed to offer the balance between effective symptom control and minimizing side effects, making it an optimal choice for patients who have been diagnosed with rheumatoid arthritis.

Safety, Side Effects, and Precautions

While Tory 90 Tablet (Etoricoxib 90) 30’s is engineered for safety and efficacy, understanding its profile is essential:

• Contraindications: This medication should not be used by individuals with known hypersensitivity to Etoricoxib. It is also contraindicated for those suffering from active peptic ulceration, gastrointestinal bleeding, or individuals who have experienced NSAID-induced asthma, rhinitis, nasal polyps, or urticaria.
• Precautions: Patients with liver dysfunction, severe heart failure, or renal impairment should exercise caution. Those with a history of gastrointestinal complications or the elderly should be monitored closely by their healthcare provider.
• Side Effects: Common side effects may include dry mouth, taste disturbances, mouth ulcers, flatulence, constipation, appetite changes, chest pain, fatigue, paraesthesia, influenza-like symptoms, and myalgia. Should these side effects persist or worsen, it is important to consult your doctor promptly.
• Drug Interactions: Tory 90 Tablet may interact with several other medications including oral anticoagulants, diuretics, ACE inhibitors, acetylsalicylic acid, cyclosporine, tacrolimus, lithium, and methotrexate, among others. Always inform your physician of your complete medication list to avoid any adverse interactions.
• Use in Pregnancy and Lactation: Etoricoxib should be avoided during late pregnancy due to the risk of premature closure of the ductus arteriosus. During the first two trimesters, it should be used only if the expected benefits outweigh the risks. Since it is unknown whether Etoricoxib is excreted in human milk, breastfeeding mothers should consult their healthcare provider before use.

Storage and Handling

For optimum performance, store Tory 90 Tablet (Etoricoxib 90) 30’s in a cool, dry place away from direct sunlight and moisture. Ensure the product is kept out of reach of children to prevent accidental ingestion.

Frequently Asked Questions (FAQs)

Q: What is Tory 90 Tablet (Etoricoxib 90) 30’s used for?
A: It is used for the effective relief of pain and inflammation specifically associated with rheumatoid arthritis.

Q: How should I take Tory 90 Tablet (Etoricoxib 90) 30’s?
A: The recommended dosage for rheumatoid arthritis is one 90 mg tablet taken once daily. Always follow the advice of your healthcare provider regarding the dosage.

Q: What are the common side effects of Tory 90 Tablet (Etoricoxib 90) 30’s?
A: Common side effects include dry mouth, taste disturbances, mouth ulcers, flatulence, constipation, appetite changes, chest pain, fatigue, paraesthesia, influenza-like symptoms, and myalgia. If side effects become severe, contact your doctor immediately.

Q: Can I use Tory 90 Tablet (Etoricoxib 90) 30’s during pregnancy?
A: It is not recommended during late pregnancy due to the potential risk to the fetus. Use during the first two trimesters only if the benefits justify the potential risks. Always consult with your healthcare provider if you are pregnant or breastfeeding.

Q: Where can I buy Tory 90 Tablet (Etoricoxib 90) 30’s in Kenya?
A: You can buy Tory 90 Tablet (Etoricoxib 90) 30’s now online in Nairobi, Nakuru, Mombasa, Eldoret, Kisumu, Kiambu, Meru, Juba (South Sudan), Kigali, Kampala, and across East Africa from HealthAlone, or visit our physical shop at Kahawa Sukari Shopping Center, Nairobi.